Odyssey Therapeutics, Inc. (ODTX)

CIK 1882782 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Odyssey Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 20268-K0001193125-26-385477
Aug 6, 202610-Q0001193125-26-335822
Aug 4, 20268-K0001193125-26-331512
Jun 23, 20268-K0001193125-26-278581
Jun 17, 20268-K0001193125-26-274291
Jun 17, 202610-Q0001193125-26-274290
Jun 5, 2026SCHEDULE 13G0000315066-26-001419
May 18, 2026SCHEDULE 13D0001072613-26-000468
May 18, 2026SCHEDULE 13D0001999371-26-011002
May 18, 2026SCHEDULE 13G0002044377-26-000002
May 15, 2026SCHEDULE 13D0001193125-26-226695
May 15, 2026SCHEDULE 13D0000950103-26-007273
May 13, 202640001999371-26-010652
May 12, 202630001012975-26-000416
May 12, 202640001012975-26-000417
May 11, 202640001193125-26-217593
May 11, 202640001193125-26-217600
May 11, 202640001193125-26-217656
May 11, 202640001193125-26-217589
May 11, 202640001193125-26-217585
May 11, 202640001193125-26-217583
May 11, 202640001193125-26-217584
May 11, 202640001193125-26-217587
May 11, 202640001193125-26-217588
May 11, 202640001193125-26-217590